ADCY2 and lip and oral cavity carcinoma: Zhao et al. found that miR-338-3p is an oncogene in mucoepidermoid carcinoma 39, while Abbas et al. discovered that miR-216a-3p may promote oral cancer progression by targeting adenylate cyclase 2 (ADCY2) 40.